AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Creative and Novel Ideas in HIV Research (CNIHR) Research Grant Initiative
The NIH OAR, NIH CFARs, and International AIDS Society (IAS) have launched the fifth round of the Creative and Novel Ideas in HIV Research (CNIHR) research grant initiative. The concept proposals are due October 16, 2015. Since 2010, the CNIHR Program has awarded more than $16.1 million to fund 44 innovative research projects in the HIV field. The intent of this program is to attract both international and U.S.-based early-stage investigators from outside the field of HIV research to help address key scientific questions in HIV research, including emerging issues of long-term survival with HIV infection, prevention of HIV ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Rilpivirine Labeling
"On August 26, 2015 the Edurant (rilpivirine) product labeling was updated to include the use of rilpivirine in combination with other antiretroviral agents for the treatment of HIV-1 infection to include treatment-naïve pediatric patients from 12 to less than 18 years of age with HIV-1 RNA less than or equal to 100,00 copies/mL. … In addition to the addition of the adolescent data to the label, changes were made the Warnings and Precautions with respect to Depressive Disorders and updates to the adrenal function subsection in section 6 Adverse Reactions."   The updated labeling will be available at the FD...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 28, 2015 Category: Infectious Diseases Source Type: news

Updates to the Adult and Adolescent Opportunistic Infections Guidelines
The Bacterial Enteric Infections section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was recently updated. This update provides new data on ciprofloxacin resistance in Shigella sonnei and improved clinical success when Clostridium difficile infection (CDI) is treated with vancomycin. Limited data suggest fecal microbiota therapy for recurrent CDI may be safe and successful in HIV-infected patients.   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 28, 2015 Category: Infectious Diseases Source Type: news

AIDSinfo Updates Consumer Fact Sheets on HIV and Women
The updated AIDSinfo consumer fact sheets offer information pertinent to women, including the use of HIV medicines to prevent mother-to-child transmission of HIV. Each fact sheet includes a summary of key points and links to additional information.   View or download the following fact sheets about HIV and women: HIV and Women Preventing Mother-to-Child Transmission of HIV The Use of HIV Medicines During Pregnancy Preventing Mother-to-Child Transmission of HIV During Childbirth Preventing Mother-to-Child Transmission of HIV After Birth Visit infoSIDA to view the fact sheets in Spanish. (Source: A...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 28, 2015 Category: Infectious Diseases Source Type: news

Large Percentage of Youth with HIV May Lack Immunity to Measles, Mumps, Rubella
"Between one-third and one-half of individuals in the United States who were infected with HIV around the time of birth may not have sufficient immunity to ward off measles, mumps, and rubella—even though they may have been vaccinated against these diseases. This estimate, from a National Institutes of Health research network, in collaboration with the Centers for Disease Control and Prevention, is based on a study of more than 600 children and youth exposed to HIV in the womb."   To learn more, view the NIH press release. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Tivicay and Triumeq Labeling
"The Tivicay (dolutegravir) and Triumeq (abacavir/dolutegravir/lamivudine) product labeling was updated with drug-drug interaction information."   The updated labeling is available at the FDA website.   More information is available: FDA: Press release AIDSinfo: Patient fact sheet on Tivicay AIDSinfo: Patient fact sheet on Triumeq (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic
Dr. Francis S. Collins, Director of the National Institutes of Health, has issued a statement outlining new high-priority areas of HIV/AIDS research. The research priorities are focused on advancing efforts to end the AIDS pandemic.   For more information, please see Dr. Collins’ statement. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

Updated AIDSinfo HIV/AIDS Glossary and Companion App Now Include Images
We are pleased to announce the release of the 8th edition of the AIDSinfo Glossary of HIV/AIDS-Related Terms and a redesign of the corresponding glossary app! This update features the addition of images and infographics highlighting select glossary terms. With definitions for more than 700 HIV/AIDS-related terms in English and Spanish, the glossary—whether online, in print, or as an app—offers a comprehensive guide to the vocabulary of HIV. The free glossary app, available for iOS and Android devices, has been redesigned with an updated look and feel. The app includes several new features that make it easy to ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

Updated HHS Perinatal Antiretroviral Treatment Guidelines Released
The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. For a complete preview of key updates to the guidelines, please see What's New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the text and tables in the PDF version of the guidelines. To view or download the guidelines, go to the Perinatal Guidelines section of AIDSinfo. Sepa...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 6, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from NIAID
July 30, 2015: HVTN 505 Vaccine Induced Antibodies Nonspecific for HIV July 23, 2015: Two Paths Pave Way for Development of a Preventive HIV Vaccine July 21, 2015: Study Finds PrEP Use Feasible Among High-Risk Groups in U.S. Community Settings July 20, 2015: Dr. Fauci at IAS 2015: Comprehensive Global Prevention Can End HIV/AIDS Pandemic July 20, 2015: Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds July 20, 2015: HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus July 20, 2015: Young South...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 31, 2015 Category: Infectious Diseases Source Type: news

FDA Approves Diagnostic Test to Differentiate Between Types of HIV Infection
"The U.S. Food and Drug Administration today [July 23, 2015] approved the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, the first FDA-approved diagnostic that differentiates between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens. …   "The Bio-Rad BioPlex 2200 HIV Ag-Ab assay is to aid in the diagnosis of infection with HIV-1 and/or HIV-2, including acute HIV-1 infection. It may be used in adults, children two years of age and older, as well as in pregnant women."   For more information, view the FDA news release. (Source: AIDSinfo At-a-Glance: Offering Information on H...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 31, 2015 Category: Infectious Diseases Source Type: news

Updated National HIV/AIDS Strategy Released
The White House Office of National AIDS Policy has released the National HIV/AIDS Strategy for the United States: Updated to 2020. This is the first update of the strategy since it was initially released in 2010. Designed to look ahead to 2020, the update includes revised steps and recommendations to meet the strategy goals.   The following resources from AIDS.gov offer more information on the updated strategy: National HIV/AIDS Strategy: Updated to 2020  Infographic: What You Need To Know Infographic: 5 Major Changes Since 2010 (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatmen...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 31, 2015 Category: Infectious Diseases Source Type: news

HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Releases Statement Regarding the START and TEMPRANO Trial Results
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents has released a statement announcing a change in the rating of the Panel’s recommendation on initiation of antiretroviral therapy (ART) based on the recently published results from the START and TEMPRANO trials. Both of these randomized controlled trials demonstrated greater clinical benefits when ART is initiated in asymptomatic HIV-infected patients who started on ART at CD4 counts >500 cells/mm^3 instead of waiting until CD4 counts decline. Based on these results, the Panel’s recommendation remains the same, that ART is recommended for a...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 28, 2015 Category: Infectious Diseases Source Type: news

CDC Updates Slide Set on the HIV Care Continuum
The Centers for Disease Control and Prevention (CDC) recently updated its HIV Care Continuum for the United States and Puerto Rico slide set. The continuum traces the steps in HIV care from diagnosis to successful treatment with antiretroviral drugs. The slide set describes the statistical methods CDC uses to monitor the continuum and includes graphs depicting nationwide progress on continuum-related goals. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 17, 2015 Category: Infectious Diseases Source Type: news

AIDSinfo Drug App Provides Easy Access to HIV-Related Drug Information
The free AIDSinfo Drug App for iOS and Android devices offers easy access to information on more than 100 HIV-related approved and investigational drugs. The information, pulled from the AIDSinfo Drug Database, includes FDA drug labels for health professionals and plain language drug summaries in English and Spanish for consumers. The app also includes additional features allowing users to bookmark drugs, make notes, or set medication reminder alarms.   To ensure that the drug information is always current, the app updates automatically when connected to a wireless or cellular data network. In addition, the app w...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 17, 2015 Category: Infectious Diseases Source Type: news